Using Facebook to Increase Spontaneous Reporting of Adverse Drug Reactions

Knežević, Marinela; Bivolarevic, Ivana C.; Peric, Tanja; Janković, Slobodan

doi:10.2165/11590110-000000000-00000

Cited by 34 publications

(22 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…This requires the performance of patientreported outcomes studies and potentially, the use of publically available data sources. In the future, data from social media may become available for use in studies [18][19][20]. If the measure of QoL includes a valuation of the impact of work loss associated with MRPs, the costs of lost work should not be included in the numerator of the cost-utility ratio, i.e., the indirect costs of MRPs should be excluded.…”

Section: Estimating Outcomes For Cost-effectiveness Analysis and Costmentioning

confidence: 99%

A Framework for Assessing the Economic Value of Pharmacovigilance in Low- and Middle-Income Countries

Babigumira

Stergachis

Choi³

et al. 2014

Drug Saf

View full text Add to dashboard Cite

Pharmacovigilance (PV) programs are an essential component of national healthcare systems. Wellfunctioning PV programs can improve population health by identifying and reducing medicines-related problems (MRPs). Many low-and middle-income countries lack functional PV systems, but this deficiency has not been described in terms of the potential economic value of strengthening PV systems. The assessment of economic value for PV can support rational decision making at the country level. We propose a framework for assessing the economic value of PV. We divide national PV systems into four levels: (1) no PV, (2) basic PV, (3) semi-functional PV, and (4) functional PV. These categories represent increasing levels of investment in PV capacity at the national or health facility level for all available medicines, including vaccines. The proposed framework can be used to estimate the costs of PV (including the value of investments to increase PV capacity and the costs of managing MRPs) and outcomes associated with PV (including improvements in morbidity, mortality, and quality of life as a result of the reduction in MRPs). The quantitative approach proposed for assessing costs and benefits uses a decision-analytic modeling framework that would estimate the value of the consequences of MRPs adjusted for their probability of occurrence. This allows the quantification of value using monetary outcomes (cost-benefit analysis), natural units (cost-effectiveness analysis), or mortality adjusted for quality of life or disability (cost-utility analysis). Evidence generated using this framework could assist policy makers, program managers, and donors in evaluating investments that aim to increase the capacity and efficiency of national and facility-level PV programs in low-and middle-income countries. Key pointsPharmacovigilance is a key but underfunded component of national healthcare programs in lowand middle-income countries.A framework is proposed for assessing the economic value of pharmacovigilance programs.Evidence generated using this framework could assist stakeholders in evaluating investments to increase the capacity and efficiency of pharmacovigilance and contribute to improving population health.

show abstract

Section: Estimating Outcomes For Cost-effectiveness Analysis and Costmentioning

confidence: 99%

A Framework for Assessing the Economic Value of Pharmacovigilance in Low- and Middle-Income Countries

Babigumira

Stergachis

Choi³

et al. 2014

Drug Saf

View full text Add to dashboard Cite

show abstract

“…42,43 A study of a Facebook group set up to capture drug adverse events showed that this approach is feasible, and several of the events were considered to be drug-related. 44 However, regulating these channels would require careful consideration and significant resources. In addition, natural biases of age, social class, education, and language, together with issues of confidentiality, misleading reports, and assigning causality, make capturing accurate data via social media hugely challenging.…”

Section: Impact On Safer Use Of Medicinesmentioning

confidence: 99%

How pharmacy's adoption of social media can enhance patient outcomes

Bell¹,

Douglas²,

Cutts³

2014

IPRP

View full text Add to dashboard Cite

Social media is progressively being used for sharing health information and for networking among health professionals and patients; this is particularly evident among the younger age groups. There is great potential for pharmacy to engage in the utilization of such platforms to improve health outcomes, and this paper explores some of the areas where social media is already in use in pharmacy and potential areas where using social media could make a positive impact on the determinants of health. The literature around this subject is limited; nevertheless, the number of published studies has increased in recent years. This paper concentrates on the use and application of social media by pharmacy to improve health outcomes. The subject was explored in five main areas: provision of medicines information, safer use of medicines, medicines use in chronic disease, implementation of evidence-based medicine and guidelines, and finally clinical research. In each of these areas, there is an increase in uptake and use of social media platforms by pharmacists and other health care professionals to improve patient outcomes. A variety of the more popular social media platforms have been used by health care professionals and the relative merits of these are discussed within each of the subject areas and consideration given to their application in pharmacy practice. It is evident that the majority of social media users fall into the younger age bracket, which is understandable. However, the majority of patients living with long-term conditions typically fall into the older age bracket (over 65 years of age) and this should be taken into account when utilizing social media platforms to improve health outcomes.

show abstract

“…Knezevic and colleagues created a FaceBook group that invited public to submit the information of the drugs they took and their adverse experiences with the drugs [16]. In a period of 7 months, the group had a total of 1,034 members, among which 21 members reported 21 different ADRs for 19 drugs and supplements such as multivitamins.…”

Section: Related Workmentioning

confidence: 99%

Mining Twitter Data for Potential Drug Effects

Jiang

Zheng

2013

Lecture Notes in Computer Science

View full text Add to dashboard Cite

Abstract. Adverse drug reactions have become one of the top causes of deaths. For surveillance of adverse drug events, patients have gradually become involved in reporting their experiences with medications through the use of dedicated and structured systems. The emerging of social networking provides a way for patients to describe their drug experiences online in less-structured free text format. We developed a computational approach that collects, processes and analyzes Twitter data for drug effects. Our approach uses a machinelearning-based classifier to classify personal experience tweets, and use NLM's MetaMap software to recognize and extract word phrases that belong to drug effects. Our results on 5 medications demonstrate the validity of our approach, and its ability to correctly extract potential drug effects from the Twitter data. It is conceivable that social media data can serve to complement and/or supplement traditional time-consuming and costly surveillance methods.

show abstract

Using Facebook to Increase Spontaneous Reporting of Adverse Drug Reactions

Cited by 34 publications

References 5 publications

A Framework for Assessing the Economic Value of Pharmacovigilance in Low- and Middle-Income Countries

A Framework for Assessing the Economic Value of Pharmacovigilance in Low- and Middle-Income Countries

How pharmacy's adoption of social media can enhance patient outcomes

Mining Twitter Data for Potential Drug Effects

Contact Info

Product

Resources

About

Using Facebook to Increase Spontaneous Reporting of Adverse Drug Reactions

Cited by 34 publications

References 5 publications

A Framework for Assessing the Economic Value of Pharmacovigilance in Low- and Middle-Income Countries

A Framework for Assessing the Economic Value of Pharmacovigilance in Low- and Middle-Income Countries

How pharmacy&#39;s adoption of social media can enhance patient outcomes

Mining Twitter Data for Potential Drug Effects

Contact Info

Product

Resources

About

How pharmacy's adoption of social media can enhance patient outcomes